Introduction {#sec1-1}
============

Due to increasing life expectancy in developing countries, the number of elderly population is increasing. The increase in the number of elderly individuals in general population has translated into increase in age-related diseases such as diabetes, hypertension, cardiovascular, cerebrovascular, and renal diseases.

In kidney diseases, the increase in elderly population is reflected as more number of elderly patients reaching end-stage renal disease (ESRD) require renal replacement therapy.\[[@ref1]\] In recent years, the number of elderly patients on renal replacement therapy had increased in developed countries. According to the United States Renal Data System, the number of elderly patients who were initiated on renal replacement therapy had increased from 7,054 in 1996 to 13,577 in 2003.\[[@ref2]\] With the advances in medical care and technology in developing countries, the number of patients entering into renal replacement therapy is rapidly increasing. The increase in elderly patients with ESRD poses challenge to nephrologist. The optimal form of renal replacement therapy in elderly is still not clear.\[[@ref3]\] Both medical and social issues have to be considered in providing good care to the elderly patients on renal replacement therapy. Hemodialysis may have some disadvantages in elderly such as hypotension and access-related issues due to atheroscelortic arteries. The care-givers have to accompany elderly patients to dialysis unit for hemodialysis. These may be the reasons for preference of peritoneal dialysis (PD) in elderly population, which is home-based.\[[@ref4]\]

In France, PD is commonly used among elderly, and more than 50% of patients on PD were more than 70 years of age. In Hong Kong, among patients on PD, 44.1% of patients were more than 65 years of age. Continuous ambulatory peritoneal dialysis (CAPD) has many advantages and disadvantages in elderly population.\[[@ref5]\] Previous studies mention that older age, female sex, and diabetes were associated with poor outcomes in patients on PD.\[[@ref6][@ref7]\] But some studies mention that the survival in elderly patients and diabetes have improved over the recent years.\[[@ref8][@ref9]\]

The optimal form of renal replacement therapy in elderly patients is still not clear. The outcomes of elderly patients on PD therapy in developing countries are less known.\[[@ref10][@ref11]\] The aim of this study is to analyze the characteristics and outcomes in elderly patients on PD and to find the factors predicting mortality in these patients. The study is also aimed to compare the patient and technique survival between diabetic and non-diabetic elderly patients on PD.

Materials and Methods {#sec1-2}
=====================

This study is a retrospective analysis of 148 elderly patients who had started on CAPD due to ESRD in the period between January 2001 and December 2015 in Sanjay Gandhi Post Graduate Institute, Lucknow, India. Of these, 28 patients were excluded from the study because of lack of proper data and few patients have their CAPD catheter inserted from other hospital.

Demographic characteristics of the patients were collected from patient records. Age, gender, comorbid status, basic renal disease, duration of PD, number of episodes of peritonitis, choice of PD (compulsory or patient preference), and duration of hemodialysis prior to CAPD were noted from patients\' record. The mode of PD (APD vs. CAPD), daily mean ultrafiltration, and biochemical parameters such as serum creatinine, serum calcium, serum phosphorus, serum albumin, hemoglobin, and intact parathyroid hormone before and after the initiation of CAPD were noted.

The number of peritonitis episodes, time to first episode, causative organism for peritonitis, exit, and tunnel infection were recorded. Factors associated with mortality as well as patient and catheter survival were analyzed. Cause of death was ascertained mainly by hospital records from our center and by death certificates issued if the patient died elsewhere other than our hospital.

Technique failure has been defined as the need for transfer to hemodialysis for more than 2 months due to infection complications, mechanical complications, inadequate ultrafiltration or clearances.

Statistical analysis {#sec2-1}
--------------------

Statistical analysis was performed using SPSS software version 11.0. Baseline characteristics were presented as mean ± standard deviation. Independent sample *t*-test was used to analyze continuous variables such as biochemical and clinical parameters. Patient and technique survival rates were calculated using Kaplan--Meier survival analysis. Predictive factors for mortality and technique failure were analyzed using Cox proportional hazard methods. Differences were considered statistically significant if *P* value is less than 0.05.

Results {#sec1-3}
=======

Of the 764 patients who were started on CAPD during the study period, 148 (19.3%) patients were more than 65 years of age. Among these patients, 28 were excluded due to nonavailability of proper data. Seven patients were lost to follow-up in different times, but the information regarding other data was available. Data were analyzed till the last date of follow-up. In Kaplan--Meier analysis, the data were censored for survival in the date of last follow-up. The mean age of the patients was 70.3 ± 5.1 years. Among these patients, 94 (80%) were males. Patients\' baseline characteristics are presented in [Table 1](#T1){ref-type="table"}. In comorbid diseases, diabetes was present in 79 (65.8%) patients, hypertension in 113 (94.2%), coronary artery disease in 30 (25%), and stroke in 3 (2.4%) patients.

###### 

Baseline characteristics of elderly PD patients

  Characteristics                   Values *n*=120   Diabetes *n*=79   Non-diabetic *n*=41   *P*
  --------------------------------- ---------------- ----------------- --------------------- -------
  Age                               70.3±5.1         70.4±5.0          70.3±5.3              0.94
  Gender                                                                                     
   Male                             96 (80%)         65                31                    0.38
   Female                           24 (20%)         14                10                    
  Comorbid diseases                                                                          
   Diabetes                         79 (65.8%)       \-                \-                    \-
   Hypertension                     113 (94.2%)      79                34                    0.001
   Coronary artery disease          30 (25%)         25                5                     
   Cerebrovascular disease          3 (2.4%)         1                 2                     0.02
   Other                            8 (6.6%)                                                 NS
  Etiology of renal disease                                                                  
   Diabetic kidney disease          75 (62.5%)       NA                NA                    NA
   Chronic glomerulonephritis       9 (7.5%)                                                 
   Chronic interstitial nephritis   18 (15%)                                                 
   Hypertensive nephrosclerosis     10 (8.3%)                                                
   Polycystic kidney disease        3 (2.5%)                                                 
   Others                           5 (4.1%)                                                 
  HD duration before CAPD           2.2±3.3 months   2.2±3.3.4         2.2±3.0               0.9

Etiologies of ESRD were diabetic nephropathy in 75 (62.5%) patients, chronic glomerulonephritis in 9 (7.5%), chronic interstitial nephritis in 18 (15%), hypertensive nephrosclerosis in 10 (8.3%), and polycystic kidney disease in 3 (2.4%).

The mean hemodialysis duration before starting PD was 2.2 ± 3.3 months. The mean PD duration was 30.2 ± 23.5 months. Only 28 (23.3%) patients were doing PD by themselves. Most of the patients were on CAPD (93.3%) and only eight patients were on APD. Around 60.8% of patients chose PD therapy by choice, and 39.2% of patients preferred PD therapy due to arteriovenous access-related problems, hypotension during hemodialysis therapy, and intolerance to hemodialysis therapy. About 90% of these patients were doing three exchanges per day. The incidence of peritonitis was one episode per 41.2 patient-months. The incidence of exit site and tunnel infection was one episode per 43.2 patient-years. A total of 55 episodes of peritonitis were documented in 120 patients. Most of the peritonitis was culture-negative (58.1%) which was followed by *Escherichia coli* (7.2%), *Pseudomonas* (7.2%), *Candida* (5.4%), klebsiella (5.4%), and other (16.7%) infections \[[Table 2](#T2){ref-type="table"}\].

###### 

Characteristics related to peritoneal dialysis in elderly patients

  Characteristics                                     Values, (frequency/mean±SD) *n*=120   Diabetes *n*=79                     Non-diabetic *n*=41                 *P*
  --------------------------------------------------- ------------------------------------- ----------------------------------- ----------------------------------- ------
  Type of PD                                                                                                                                                        
   CAPD                                               112 (93.3%)                           74                                  5                                   0.8
   APD                                                8 (6.7%)                              5                                   3                                   
  Decision for PD                                                                                                                                                   
   By choice                                          73 (60.8%)                            45                                  28                                  0.22
   Compulsory                                         47 (39.2%)                            34                                  13                                  
  Duration of PD                                      30.2±23.5 months                      29.7±23.2                           31.1±21.2                           0.75
  Peritonitis incidence                               1 episode per 41.2 patients-months    1 episode per 48.9 patient-motnhs   1 episode per 31.9 patient-months   0.24
  Catheter exit site and tunnel infection incidence   1 episode per 43.2 patient-year       1 episode per 39.16 patient-year    1 episode per 53.2 patient-year     0.55
  Organism                                                                                  \-                                  \-                                  \-
   Candida                                            3 (5.4%)                                                                                                      
   Aspergillus                                        1 (1.8%)                                                                                                      
   Citrobacter                                        1 (1.8%)                                                                                                      
   E. Coli                                            4 (7.2%)                                                                                                      
   MRSA                                               2 (3.6%)                                                                                                      
   MSSA                                               1 (1.8%)                                                                                                      
   Pseudomonas                                        4 (7.2%)                                                                                                      
   Klebsiella                                         3 (5.4%)                                                                                                      
   Mycobacterium                                      2 (3.6%)                                                                                                      
   Streptococcus                                      1 (1.8%)                                                                                                      
   Pheohypomycosis                                    1 (1.8%)                                                                                                      
   Culture negative                                   32 (58.1%)                                                                                                    
  Peritonitis (No of episodes)                        55                                    36                                  25                                  0.1
  Urine output at beginning of PD                     412±302                               392.4±253.7                         452.4±379.1                         0.30
  Ultrafiltration at beginning of PD                  1081±290                              1104.4±283.6                        1036.5±300.8                        0.22

During the maximum follow-up period of 7.1 years, only 20 (16.6%) remained on PD. One patient underwent renal transplant and 15 (12.2%) patients were transferred to hemodialysis. Among the patients who were transferred to hemodialysis, 10 (66.6%) were due to peritonitis. Ninety patients (75%) died during the follow-up period. Most of the patients died due to cardiovascular events (56.6%), peritonitis (18.8%), sepsis other than peritonitis (12.2%), cerebrovascular events (4.4%), and other causes (7.7%) \[[Table 3](#T3){ref-type="table"}\].

###### 

Outcomes of peritoneal dialysis in elderly patients

  Outcomes                                           All patients *n*=120   Diabetic (*n*=79)   Non-diabetic (*n*=41)   *P*
  -------------------------------------------------- ---------------------- ------------------- ----------------------- ------
  Death (6 patients died after transferring to HD)   90 (75%)               57 (72%)            33 (80.4%)              0.31
  Cause of death (*n*=90)                                                                                               0.65
   Cardiovascular                                    51 (56.6%)             33 (57.8%)          18 (54.5%)              
   Peritonitis                                       17 (18.8%)             10 (17.5%)          7 (21.2%)               
   Sepsis other than peritonitis                     11 (12.2%)             6 (10.5%)           5 (15.1%)               
   Cerebrovascular                                   04 (4.4%)              2 (3.5%)            2 (6.1%)                
   Others                                            07 (7.7%)              5 (8.7%)            2 (6.1%)                
  Death with catheter                                84 (70%)               53 (67%)            31 (75.6%)              0.33
  Transfer to hemodialysis                                                                                              
   Cause of transfer to HDpermanently (*n*=15)       15 (12.5%)             9 (11.3%)           6 (14.6%)               0.5
   Due to peritonitis                                10 (66.6%)             6 (66.6%)           4 (66.6%)               0.71
   Due to inadequate dialysis                        2 (13.3%)              1 (11.1%)           1 (16.6%)               
   Due to mechanical complication                    3 (20%)                2 (22.2%)           1 (16.6%)               
  Patient on PD treatment                            20 (16.6%)             16 (20.2%)          4 (9.7%)                0.19
  Patient underwent transplant                       1 (0.83%)              1 (1.2%)            0                       0.59

The mean survival time of patients was 38.2 ± 2.6 months (diabetes: 38.4 ± 3.3 and non-diabetes: 37.6 ± 4.3) based on Kaplan--Meier survival analysis. The survival rates were 91.2%, 58.6%, 45.3%, 35.5%, and 22.8% at 1, 2, 3, 4, and 5 years, respectively \[[Table 4](#T4){ref-type="table"}\]. Patient survival rates of diabetic versus non-diabetic at 1, 2, 3, 4, and 5 years were 89.3% versus 92.3%, 58.1% versus 59.7%, 47.3% versus 41.8%, 37.1% versus 32.8%, and 21.8% versus 23.9%, respectively. No significant difference in the survival rates was observed between the diabetic and non-diabetic elderly PD populations (log rank = 0.81).

###### 

Patient and Technique survival rates in elderly PD patientss

  Year         Number of patients entering each year for analysis   Patient survival   Technique survival (death censored)
  ------------ ---------------------------------------------------- ------------------ -------------------------------------
  1^st^ year   120                                                  91.2%              94.8%
  2^nd^ year   96                                                   58.6%              90.6%
  3^rd^ year   55                                                   45.3%              85.3%
  4^th^ year   38                                                   35.5%              78.1%
  5^th^ year   38                                                   22.8%              71.7%

Predictors of increased mortality were increased serum phosphorus (Hazard Ratio, HR 1.34), peritonitis episodes (HR 1.46), urine output \<400 mL (HR 1.8), and ultrafiltration \<1000 mL/day (HR 1.74) at beginning of PD.

The mean death censored technique survival duration was 92.0 ± 5.1 months based on Kaplan--Meier survival analysis. The overall technique survival rates were 94.8%, 90.6%, 85.3%, 78.1%, and 71.7%% at 1, 2, 3, 4, and 5 years, respectively. Technique survival rates of diabetic versus non-diabetic at 1, 2, 3, 4, and 5 years were 96.9% versus 90.1%, 92.2% versus 87.4%, 86.3% versus 83.3%, 79.7 versus 75.5%, and 68.5% versus 75.5%, respectively. No significant differences in technique survival rates were observed between the diabetic and non-diabetic elderly patients on PD (log rank = 0.56). None of the factors was predictive of technique survival in these patients.

Discussion {#sec1-4}
==========

This study aimed at analyzing the clinical characteristics, survival outcomes, and predictors of mortality in elderly PD population in our center. We also compared the patient and technique survival between diabetic and non-diabetic elderly PD population.

The elderly PD population in our study accounted for 19.1% of all patients on PD in our center.

Patient survival {#sec2-2}
----------------

In our study, the mean survival time of elderly patients on PD was 38.2 ± 2.6 months. The survival rates were 91.2%, 58.6%, 45.3%, 35.5%, and 22.8% at 1, 2, 3, 4, and 5 years, respectively. This survival rate is less in comparison to a previous study by Prasad *et al*.\[[@ref12]\] in Indian population where the mean age group of the PD population was 56 ± 10 years. In another study from north India, where the mean age group was 60.2 ± 9.2 years, the overall survival rate at 2 and 5 years was 53% and 10%, respectively. Our study included elderly population with mean age group of 70.3 ± 5.1 years having better survival rate compared with this Indian study.\[[@ref11]\] Another study from Hong Kong, where most of the elderly people were on PD, the 2- and 5-year survival rates were 88% and 55%, respectively.\[[@ref7]\] Our study has comparatively less survival rates than this study; probably most of the patients (39.2%) were started on PD due to access failure-related problems unlike their PD first policy. Another study from Turkey by Sakaci T *et al*.\[[@ref10]\] regarding mortality in elderly patients on PD showed similar survival rates like our study.

In our study, 79 (65.8%) patients were diabetic. This percentage was high compared with previous studies. But this is similar to other Indian studies\[[@ref11][@ref12][@ref13]\] where most of the patients on PD had diabetic nephropathy as the cause of ESRD. There was no significant difference in patient survival rate between elderly diabetic and non-diabetic populations in our study. The majority of the studies mentioned that patient survival is lower in diabetic patients on PD. Prasad *et al*.\[[@ref12]\] found that patient survival was inferior in diabetic patients on PD compared with non-diabetic population. Studies done by Viglino *et al*.\[[@ref14]\] and Zimmerman *et al*.\[[@ref15]\] also found poor survival rates in diabetic PD population. As our study did not find any significant difference in survival rates between these two groups, diabetes should not deter renal physicians from starting PD as a form of renal replacement therapy (RRT) in elderly population.

Most of the deaths, which occurred in our study groups were due to cardiovascular (56.6%) causes and infection (31.1% Peritonitis was the cause of death in 17 patients (18.8%). There was no difference in the peritonitis rates between diabetic and nondiabetic elderly PD populations. Our study was similar to other studies in that cardiovascular causes are the most common cause of death in these patients.\[[@ref11][@ref12]\] Predictors of mortality in elderly patients on PD were Ultrafiltration (UF) less than 1000 mL/day at beginning of PD, urine output less than 400 mL/day, increased episodes of peritonitis, and increased serum phosphorus. In contrast to other studies,\[[@ref13]\] age and presence of other comorbid conditions did not affect patient survival in multivariate Cox proportional hazard model.

Technique survival {#sec2-3}
------------------

The mean technique survival duration was 92.0 ± 5.1 months. The technique survival rates in our study were 94.8%, 90.6%, 85.3%, 78.1%, and 71.7% at 1, 2, 3, 4, and 5 years, respectively. There was no significant difference between technique survival rates between diabetic and non-diabetic elderly PD population. These data were consistent with other studies in literature. Our study could not find any predictive factors for technique survival in this study population. This is similar to the study done by SakacI T *et al*. in elderly patients on PD.\[[@ref10]\]

The most common cause of technique failure in our study was due to peritonitis and the next being due to inadequate ultrafiltration. This is similar to most of the studies where peritonitis is the common cause for technique failure.\[[@ref16][@ref17][@ref18]\] In this study, we used technique failure as a need for transfer to HD permanently. Some of the patients are reinitiated on PD successfully after catheter removal following peritonitis. The peritonitis rate in our study is lower than that reported by other studies done previously by Vikrant *et al*.\[[@ref11]\] This may be due to improved connecting systems and proper training of the patients and relatives in our center. The relative risk of developing peritonitis was not different between diabetic and non-diabetic elderly population. This is similar to the other previously published studies which showed no difference in peritonitis and technique survival rates between diabetic and non-diabetic patients on PD.\[[@ref14][@ref19]\]

Even though the mortality rates are high in elderly patients on PD, these patients had good technique survival rates and comparatively equal survival rates as hemodialysis\[[@ref20]\] as reported by one Indian study.\[[@ref21]\] There was no difference between diabetic and non-diabetic elderly patients on PD in terms of patient and technique survival. PD can be a good option of RRT in elderly diabetic patients.

The strength of this study is that a large number of elderly patients were included. This is probably one of the Indian studies with a large number of elderly patients on PD. The limitations in our study are we did not measure the clearance and transport status in these patients. The outcomes of the patients related to clearance had not been evaluated in this study. The retrospective nature is also one of the limitations of this study.

Conclusion {#sec1-5}
==========

Mortality in our study was higher in elderly patients on PD. Factors affecting survival in elderly patients on PD are low urine output, low mean ultrafiltration at beginning of PD, high serum phosphorus, and presence of peritonitis episodes. Patient and technique survival rates were comparable between diabetic and non-diabetic elderly patients on PD.
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